Maternal & Child Health Research Institute (MCHRI)
Showing 81-100 of 1,214 Results
-
Christopher Bennett
Assistant Professor of Emergency Medicine (Adult Clinical/Academic)
BioI am a board-certified emergency physician and researcher at Stanford, where I bridge clinical practice with health innovation. In addition to being faculty in the Department of Emergency Medicine, I hold affiliations with the Stanford Institute for Human-Centered AI (HAI), the Center for AI in Medicine & Imaging (AIMI), and the Center for Digital Health (CDH).
My work leverages data-informed precision medicine with the goal of transforming healthcare delivery—especially for transmissible infectious diseases. As an NIH funded investigator, I lead a research group that designs solutions to improve patient outcomes and inform policy. I bring extensive experience from training at Duke, Harvard, and Stanford, and a proven track record of leadership from serving on the Society for Academic Emergency Medicine (SAEM) Board of Directors, the SAEM Foundation Board of Trustees.
I am passionate about collaboration to pioneer digital health strategies that revolutionize care and drive tangible impact. -
Rachel Bensen
Clinical Associate Professor, Pediatrics - Gastroenterology
Current Research and Scholarly InterestsMy research focuses on improving health care delivery systems for children, adolescents and young adults with chronic illness and their families. I have particular interests in the development of chronic disease self-management skills, assessment of patient reported outcomes, the transition from pediatric to adult-oriented health care, and comprehensive programs to support families caring for a child with chronic illness.
-
David Bergman
Associate Professor of Pediatrics (General Pediatrics) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsMy research has involved the use of new technologies to create different types of patient-doctor transactions. I am also interested in how these new transactions impact clinical care processes. Current work includes the evaluation of a patient portal for children with cystic fibrosis, the use of telemedicine to bring asthma experts into the schools and the attitudes of teens and parents about the use of a secure patient portal for teens.
-
Michele Berk, Ph.D.
Associate Professor of Psychiatry and Behavior Sciences (Child and Adolescent Psychiatry and Child Development)
Current Research and Scholarly InterestsThe focus of my research is on adolescent suicidal and self-harm behavior. I am currently one of four Principal Investigators of a multisite NIMH-sponsored RCT of DBT for adolescents at high risk for suicide (NCT01528020: Collaborative Adolescent Research on Emotions and Suicide [CARES], PI: Linehan, McCauley, Berk, & Asarnow) aimed at evaluating the efficacy of DBT with adolescents compared to a combined individual and group supportive therapy control condition (IGST).
-
Daniel Bernstein
Alfred Woodley Salter and Mabel G. Salter Endowed Professor of Pediatrics
Current Research and Scholarly Interests1. Using iPSC-derived cardiomyocytes to understand hypertrophic cardiomyopathy and heart failure associated with congenital heart disease.
2. Role of alterations in mitochondrial dycamics and function in normal physiology and disease.
3. Differences between R and L ventricular responses to stress,
4. Immune biomarkers of risk after pediatric VAD implantation.
5. Biomarkers for post-transplant lymphoproliferative disorder. -
Jon Bernstein
Professor of Pediatrics (Genetics) and, by courtesy, of Genetics
Current Research and Scholarly InterestsMy research is focused on the diagnosis, discovery and delineation of rare genetic conditions with a focus on neurodevelopmental disorders. This work includes the application of novel computational methods and multi-omics profiling (whole genome sequencing, long-read DNA sequencing, RNA sequencing, methylomics, metabolomics). I additionally participate in an interdisciplinary project to develop induced pluripotent stem cell and assembloid models of genetic neurodevelopmental disorders.
-
Edward Bertaccini
Professor of Anesthesiology, Perioperative and Pain Medicine (MSD), Emeritus
Current Research and Scholarly Interestsmolecular modeling of anesthetic-protein interactions, molecular modeling of the ligand-gated ion channels
-
Alice Bertaina MD, PhD
Lorry I. Lokey Professor
Current Research and Scholarly InterestsDr. Bertaina is a highly experienced clinician and will play a key role in supporting Section Chief Dr. Rajni Agarwal and Clinical Staff in the Stem Cell Transplant Unit at Lucile Packard Children’s Hospital. She will also continue her research on immune recovery and miRNA, understanding the mechanisms underlying immune reconstitution, Graft-versus-Host Disease (GvHD), and leukemia relapse after allogeneic HSCT in pediatric patients affected by hematological malignant and non-malignant disorders.
-
Carolyn Bertozzi
Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology
BioCarolyn Bertozzi is the Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor in the School of Humanities and Sciences and Professor, by courtesy, of Chemical and Systems Biology and of Radiology at Stanford University, and an Investigator of the Howard Hughes Medical Institute. She completed her undergraduate degree in Chemistry from Harvard University in 1988 and her Ph.D. in Chemistry from UC Berkeley in 1993. After completing postdoctoral work at UCSF in the field of cellular immunology, she joined the UC Berkeley faculty in 1996. In June 2015, she joined the faculty at Stanford University and became the co-director and Institute Scholar at Sarafan ChEM-H.
Prof. Bertozzi's research focuses on fundamental studies of disease-associated glycobiology and the development of new therapeutic modalities that target these pathways. Her inventions include bioorthogonal chemistries for in vivo imaging and bioconjugation, work for which she received the 2022 Nobel Prize in Chemistry. As well, her lab has developed next generation antibody-drug conjugates, lysosome-targeting chimeras (LYTACs), antibody-enzyme conjugates and antibody-lectin chimeras. Several of these new therapeutic modalities have been translated into clinical candidates for treatment of cancer and autoimmune diseases.
In addition to the Nobel Prize, Prof. Bertozzi has been recognized with many honors and awards for both her research and teaching accomplishments. For example, she is an elected member of the National Academy of Sciences, the National Academy of Medicine, the National Inventors Academy and the National Academy of Engineering, the American Academy of Arts and Sciences, the German Academy of Sciences Leopoldina, and she is a Foreign Fellow of the Royal Society. In addition, Prof. Bertozzi received the Priestley Medal of the American Chemical Society, the Welch Award, the Wolf Prize in Chemistry, the Heineken Prize, Lemelson-MIT award for inventors, and a MacArthur "Genius Award". -
Vivek Bhalla, MD
Associate Professor of Medicine (Nephrology)
Current Research and Scholarly InterestsDr. Bhalla's two primary research interests are in the role of the kidney in diabetes and hypertension. We use molecular, biochemical, and transgenic approaches to study: (1) mechanisms diabetic kidney disease disease including the role of the endothelium to regulate inflammation and kidney injury; and (2) regulation of tubular transport of glucose, sodium, and potassium. These latter studies have treatment implications in diabetes, kidney disease, and hypertension.
-
Rashmi Parekh Bhandari
Clinical Professor, Anesthesiology, Perioperative and Pain Medicine
Current Research and Scholarly InterestsClinical interventions, treatments, and outcomes in pediatric pain management
-
Ami Bhatt
Professor of Medicine (Hematology) and of Genetics
Current Research and Scholarly InterestsThe Bhatt lab is exploring how the microbiota is intertwined with states of health and disease. We apply the most modern genetic tools in an effort to deconvolute the mechanism of human diseases.
-
Nidhi Bhutani
Associate Professor of Orthopaedic Surgery
Current Research and Scholarly InterestsThe long-term goal of our research is to understand the fundamental mechanisms that govern and reprogram cellular fate during development, regeneration and disease.
-
Vinod (Vinny) K. Bhutani
Professor of Pediatrics (Neonatology) at the Lucile Salter Packard Children's Hospital, Emeritus
Current Research and Scholarly InterestsNeonatology; newborn jaundice, bilirubin biology and kernicterus prevention; pulmonary physiology, pulmonary functions and neonatal ventilation. To promote newborn screening for G6PD deficiency in USA.
-
Y. Katherine Bianco
Clinical Professor, Obstetrics & Gynecology - Maternal Fetal Medicine
BioMy clinical interest in pregnancies complicated with birth defects has led my underlying research interests in genomic abnormalities in the human trophoblast carrying to faulty placentation. The latter began with initial work during K12 and KO8 funding. I took a great interest in the human placenta as it carries potential advantages over other tissues sources: first, this highly metabolically active organ is the potential source of many transcripts. Second, the placenta forms at a very early stage of embryonic development, potentially allowing detection of primary alterations as compared to secondary changes that may mask the underlying causal phenomena. Finally, studying early placentation may provide targets for development of novel molecular approaches, such as up-regulate or down-regulate genes, the protein products of which could potentially serve as molecular surrogates for diagnosis and treatment of pregnancy complication such as miscarriages, pre-eclampsia, pregnancy induced hypertension and intrauterine growth retardation. This work has led to the first Trisomy 21, Trisomy 18, trisomy 13 cell lines established from human placentas making it possible to apply gene editing in the early stages of human trophoblast development.
As my primary clinical responsibility involves treating patients needing medical care and support through their high risk pregnancies, I am interested in factors that may impact outcomes, such as prenatal screening and diagnosis, maternal heart conditions, labor and delivery management, and safety approaches for the second stage of labor. In investigating length of labor and approaches to shorten the second stage, I have found methods of improving perinatal outcomes in diverse maternal populations.
With regards to my interest in fetal medicine, I have worked in collaboration with other specialists such as radiologists and pediatric cardiologists utilizing imagining studies to assess and determine successful perinatal care and fetal survival. -
Mahamaya Biswal
Postdoctoral Scholar, Molecular and Cellular Physiology
BioMahamaya is a postdoctoral researcher in the Department of Molecular and Cellular Physiology at Stanford University, where she specializes in Cellular and structural biology with a focus on membrane protein biogenesis, quality control, and the development of innovative nanobody technologies. Her research integrates advanced cryo-electron microscopy (cryo-EM), cell biology, and nanobody engineering to unravel the mechanisms governing the assembly and maturation of membrane protein biogenesis factor hubs with a focus on Voltage gated ion channels as a model substrate.
Dr. Biswal’s scientific journey began with an integrated M.Tech in Biotechnology degree from D.Y. Patil University, India, where she conducted foundational research on bacterial persister cell formation at BARC and characterized breast cancer proteins ZBRK1 and BRCA1 at ACTREC,. After spending a brief time in biotech industry at Yashraj Biotechnology Ltd., Mumbai, optimizing purification pipelines for cancer antigens used in diagnostic kits and facilitating technology transfer from R&D to manufacturing, she moved to US to join UC Riverside’s PhD program under Department of Biochemistry and supervision of Dr. Jikui Song. She made significant advances in understanding the structural dynamics of SARS-CoV-2 proteins. Notably, she solved the X-ray crystal structure of the NSP7-8 complex, a key cofactor for the viral replicase, and also elucidated the interaction between the viral nucleocapsid protein and human G3BP1. Her doctoral and postdoctoral work has also contributed to studies on viral immune evasion, including the structural basis for STAT2 antagonization by DENV2 NS5.
At Stanford, Dr. Biswal has expanded her expertise to the structural and functional study of G protein-coupled receptors (GPCRs) and currently focusing on gaining mechanistic insights on Membrane protein biogenesis factor hubs by combining cell biology and structural biology expertise. She is also developing nanobody libraries targeting synaptic vesicles and bacterial death effectors for in situ tomography and potential therapeutic applications respectively. Dr. Biswal is a committed mentor, having supervised graduate and undergraduate students, and is dedicated to fostering diversity and inclusion in science through active involvement in organizations such as AWIS, BioAIMS, and BSS (India). Her scientific contributions have been recognized with honors including the HEERF Dissertation Year Fellowship, the Mary K. and Randolph T. Wedding Prize, and best poster awards at UC Riverside. Dr. Biswal’s long-term vision is to lead a research program that translates structural insights into therapeutic strategies for neurological and infectious diseases, advancing both scientific knowledge and the next generation of scientists.
